Heterozygous or Homozygous Familial Hypercholesterolemia
1 clinical trials · Condition
◉ Watch Heterozygous or Homozygous Familial Hypercholesterolemia
| Record | Firm | Date |
|---|---|---|
| Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies (NCT05682378) | Novartis Pharmaceuticals | 2023-02-10 |
Track Heterozygous or Homozygous Familial Hypercholesterolemia automatically
Every clearance here is in the API, with alerts when new ones post.